AbbVie EBIT 2010-2024 | ABBV

AbbVie EBIT for the quarter ending December 31, 2024 was $-1.490B, a 146.64% decline year-over-year.

  • AbbVie 2024 EBIT was 9.137B, a 28.38% decline from 2023.
  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.
  • AbbVie 2022 EBIT was 18.117B, a 1.08% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

AbbVie EBIT 2010-2024 | ABBV

  • AbbVie 2024 EBIT was 9.137B, a 28.38% decline from 2023.
  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.
  • AbbVie 2022 EBIT was 18.117B, a 1.08% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B